Showing 7,981 - 8,000 results of 104,764 for search '(( i wt decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.62s Refine Results
  1. 7981

    Upregulation of astroglial Cx30 decreased LTP and recognition memory. by Eléonore Hardy (15208385)

    Published 2023
    “…LTP maintenance for the last 10 min (30–40 min) was decreased for AAV-GFAP-Cx30 (<i>n =</i> 9 slices from 5 mice) compared to AAV-GFAP-GFP (<i>n</i> = 8 slices from 5 mice); *<i>p</i> < 0.05, Welch’s <i>t</i> test). …”
  2. 7982
  3. 7983
  4. 7984

    Prenatal treatment decreases proliferation and increases apoptosis in small intestine. by Fátima Ramalhosa (3095712)

    Published 2016
    “…(B) Proliferation rate is decreased within the crypts in <i>iuGC</i> rats, n = 3, 4, 5 CTR and n = 3, 6, 3 <i>iuGC</i>. …”
  5. 7985
  6. 7986

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  7. 7987

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  8. 7988

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  9. 7989

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  10. 7990

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  11. 7991
  12. 7992

    Treatment with rSFRP4 results in decreased Wnt signalling. by Caroline E. Ford (289563)

    Published 2013
    “…(<b>B</b>) Representative immunoblots showing increased SFRP4 and decreased nuclear β-catenin protein expression in OVCAR3 cells following 72 hours treatment with rSFRP4 (5 µg/ml). …”
  13. 7993
  14. 7994
  15. 7995
  16. 7996
  17. 7997
  18. 7998
  19. 7999

    Inhibition of TGF-β decreases endothelial barrier function in vivo. by Tony E. Walshe (269700)

    Published 2013
    “…Scale = 0.5 µm. (D) Immunoprecipitation of occludin and western blotting for zo-1 demonstrated a significant decrease in association between occludin and zo-1 in lysates prepared from retinas of sEng-expressing mice (day 7). …”
  20. 8000